United States · FDA National Drug Code directory
Guaifenesin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81033-102_316ac9e6-8d03-f55a-e063-6294a90a8540
- Product NDC
- 81033-102
- Form
- LIQUID
- Composition / generic term
- Guaifenesin
- Labeler
- KESIN PHARMA CORPORATION
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20231120
- Source listing expiry
- 20261231
Source-listed ingredients
- GUAIFENESIN — 100 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 50 CUP, UNIT-DOSE in 1 CARTON (81033-102-51) / 5 mL in 1 CUP, UNIT-DOSE (81033-102-05) · 81033-102-51
- 50 CUP, UNIT-DOSE in 1 CARTON (81033-102-52) / 10 mL in 1 CUP, UNIT-DOSE (81033-102-10) · 81033-102-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →